The pharmaceutical landscape is experiencing a shift with the emergence of GLP-1 transdermal systems . These innovative formulations offer a promising alternative to administering glucagon-like peptide-1 https://caoimhedvsr179594.iyublog.com/39744035/glp-1-patches-a-new-way-to-control-diabetes